Skip to content

Application of rectus abdominis sheath nerve block in laparoscopic radical gastrectomy based on surgical incision

Application of rectus abdominis sheath nerve block in laparoscopic radical gastrectomy based on surgical incision

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038846
Enrollment
Unknown
Registered
2020-10-06
Start date
2021-01-04
Completion date
Unknown
Last updated
2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer of the stomach

Interventions

Incision-based rectus sheath nerve block combined with general anesthesia group:Guided by the surgical incision, the rectus sheath block was performed by ultrasound (0.4% ropivacaine 40-50ml at the na
General anesthesia group:Propofol pumping combined with sevoflurane inhalation, dexmedetomidine and remifentanil pumping were maintained, with intermittent administration of cisatracuramine

Sponsors

Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Sign informed consent; 2. Aged 18-75 years; 3. ASA grading II~III; 4. Patients planning to undergo elective laparoscopic surgery for gastric cancer.

Exclusion criteria

Exclusion criteria: 1. People with contraindications to regional block techniques (allergic to local anesthetics, infection around the puncture site, and coagulation disorders); 2. A history of painkiller dependence; 3. Patients with dementia or severe cognitive impairment; 4. Any cerebrovascular accidents occurred within 5.3 months, such as stroke, transient ischemic attack (TIA), etc. 5. Patients with severe hypertension or unstable preoperative blood pressure control; 6. Anyone who has difficulty communicating; 7. The incision is beyond the rectus sheath.

Design outcomes

Primary

MeasureTime frame
Intraoperative remifentanil requirement;

Secondary

MeasureTime frame
The amount of anesthetic drugs, vasoactive drugs and fluid in and out during operation;The severity, duration, and duration of delirium;Intraoperative hemodynamic fluctuations;Resting and exercise pain scores at each follow-up time point (NRS score, 0-10);Postoperative main organ complications and length of hospital stay;Mortality at 30 days after surgery (telephone follow-up);Patients' waking time, extubation time, and time to and from PACU;The dosage of sufentanil 24h and 48h after operation and the dosage of other analgesic drugs;The first time of ventilation and the first time of getting out of bed after surgery;

Countries

China

Contacts

Public ContactGuang-hong Xu

Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University

xuguanghong2004@163.com+86 13856949535

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026